Phase:

Evaluate 01

3–5 weeks

Every year we meet with between 20 and 30 curious researchers, academics or clinicians to discuss findings or data that may have commercial potential. The first thing we evaluate is the quality of the scientific data you present and the IPR situation (if your idea is actually new and possible to protect).

Around half of these cases move on to our Preincubator phase.